DBV Technologies S.A.
DBVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; 78 institutions reported holding it in 13F filings for Q2 2026, worth $345.7M in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesDBVTF
13F holders, Q1 2022
Institutional positions in DBV Technologies S.A. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −10 vs. Q4 2021
- Shares held
- 20.4M
- −951.5K (−4.5%) vs. Q4 2021
- Total value
- $32.9M
- −$1.81M (−5.2%) vs. Q4 2021
- New holders
- 3
- 4 more added
- Sold out
- 13
- 4 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $345.7M |
| Q1 2026 | 71 | $433.6M |
| Q4 2025 | 52 | $302.1M |
| Q3 2025 | 33 | $65.2M |
| Q2 2025 | 29 | $66.2M |
| Q1 2025 | 16 | $16.8M |
| Q4 2024 | 18 | $8.46M |
| Q3 2024 | 24 | $11.3M |
| Q2 2024 | 30 | $13.7M |
| Q1 2024 | 33 | $29.2M |
| Q4 2023 | 40 | $36.6M |
| Q3 2023 | 38 | $60.4M |
| Q2 2023 | 36 | $87.4M |
| Q1 2023 | 34 | $71.3M |
| Q4 2022 | 38 | $68.0M |
| Q3 2022 | 36 | $61.1M |
| Q2 2022 | 38 | $66.8M |
| Q1 2022 | 31 | $32.9M |
| Q4 2021 | 41 | $34.7M |
| Q3 2021 | 51 | $179.8M |
| Q2 2021 | 48 | $243.5M |
| Q1 2021 | 44 | $197.5M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding DBV Technologies S.A.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 14,614,264 | $23.2M | 0.13% | 00.0% | Unchanged |
| Boxer Capital, LLC | 2,134,598 | $3.39M | 0.17% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 1,305,392 | $2.08M | 0.00% | +28,018+2.2% | Added |
| BlackRock Inc. | 687,341 | $1.09M | 0.00% | +97,412+16.5% | Added |
| Ikarian Capital, LLC | 316,939 | $1.05M | 0.32% | +6,829+2.2% | Added |
| Morgan Stanley | 560,121 | $890.0K | 0.00% | −326,953−36.9% | Reduced |
| Nan Fung Group Holdings Ltd | 370,950 | $590.0K | 0.28% | 00.0% | Unchanged |
| Cowen and Company, LLC | 160,764 | $256.0K | 0.03% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 32,861 | $52.0K | 0.00% | 00.0% | Unchanged |
| Janney Montgomery Scott LLC | 29,700 | $47.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 23,666 | $37.0K | 0.00% | 00.0% | Unchanged |
| Optiver Holding B.V. | 22,472 | $36.0K | 0.00% | −568,815−96.2% | Reduced |
| Millennium Management LLC | 22,116 | $35.0K | 0.00% | +22,116 | New |
| Personal Cfo Solutions, LLC | 16,088 | $26.0K | 0.01% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 14,400 | $23.0K | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 14,713 | $23.0K | 0.00% | +14,713 | New |
| UBS Group AG | 7,957 | $13.0K | 0.00% | +7,957 | New |
| Heritage Wealth Advisors | 6,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 4,255 | $6.76K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 3,100 | $4.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,730 | $3.00K | 0.00% | −930−35.0% | Reduced |
| Wells Fargo & Company | 1,861 | $3.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 776 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 855 | $1.00K | 0.00% | 00.0% | Unchanged |
| Exane Derivatives | 101 | $161 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 50 | $0 | 0.00% | −500−90.9% | Reduced |
| JPMorgan Chase & Co | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 75 | $0 | 0.00% | +14+23.0% | Added |
| TCI Wealth Advisors, Inc. | 20 | $0 | 0.00% | 00.0% | Unchanged |
| Mark Sheptoff Financial Planning, LLC | 300 | $0 | 0.00% | 00.0% | Unchanged |
| Annapolis Financial Services, LLC | 270 | $0 | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 0 | $0 | 0.00% | −77,067−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −53,242−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −26,663−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −25,229−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −23,507−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −1,666−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −1,446−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −1,470−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −355−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −428−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −74−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −196−100.0% | Sold out |